Convergent Therapeutics, Inc.
Developing next-generation targeted combination therapies to advance the care of cancer patients.
39 employees · est. 2021 · Cambridge, United States
TransCode Therapeutics, Inc.
Delivering a cancer-free future
11 employees · est. 2016 · Newton, United States
TransCode Therapeutics, Inc. is the older company (2021 vs 2016).
Side-by-Side Comparison
| Metric | Convergent Therapeutics, Inc. | TransCode Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2016 older |
| Headquarters | ||
| Headquarters | Cambridge, United States | Newton, United States |
| Employees | ||
| Employees | 39 | 11 |
| Industry | ||
| Industry | Not tracked yet | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $132.50M | $28.05M |
| Funding Rounds | ||
| Funding Rounds | 4 | 10 |
| Services | ||
| Services | Development of targeted radiotherapies, Alpha radioantibody innovation, Clinical trials for cancer treatments | Not tracked yet |
| Target Customers | ||
| Target Customers | Cancer patients, Oncologists, Healthcare institutions | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Clinical-stage Biotechnology, Cancer Treatment, Targeted Combination Therapies, Radiopharmaceutical Therapies, Prostate Cancer, Dual-targeted Radionuclide Therapy, Targeting Agents, Monoclonal Antibodies, Ligand Targeting, PSMA-targeting, Internalized Payload Delivery, Alpha Particle Emitters, Radioisotope Therapy, Oncological Research, Issued Patents | Cancer Therapeutics, Targeted Therapies, Biomarker Targeting, RNA-based Therapies, Gene Therapy, Oncology Research, Drug Delivery Technology, MicroRNA-10b, PD-L1 Modulation, CRISPR/Cas9, Cancer Vaccine Development, Tumor Microenvironment, Cancer Treatment Innovation, Precision Medicine, Immunotherapy |
| Website | ||
| Website | convergentrx.com | transcodetherapeutics.com |
About Convergent Therapeutics, Inc.
Convergent Therapeutics, Inc., founded in 2021 and headquartered in the United States, is a clinical-stage biotechnology company focused on developing next-generation targeted combination therapies to advance cancer treatment. The company builds on breakthrough research from Dr. Neil Bander at Weill...
About TransCode Therapeutics, Inc.
TransCode Therapeutics, Inc. is a biotechnology startup founded in 2016, with a mission to deliver a cancer-free future for all cancer patients. The company focuses on the intelligent design and efficient delivery of targeted therapeutics, particularly TTX-MC138, which targets microRNA-10b, consider...
We will tell you when either one moves
BounceWatch watches Convergent Therapeutics, Inc. and TransCode Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Convergent Therapeutic... and TransCode Therapeutics... — by email.
Frequently Asked Questions
Compare Convergent Therapeutics, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Convergent Therapeutics, Inc. on 9 Jun 2026, and TransCode Therapeutics, Inc. on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
